NORTHWEST BIOTHERAPEUTICS INC (NWBO) Free cash flow 2018–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$46.3MFY2025 · since FY2018: -$34.6M → -$46.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$46.3M | +20.3% |
| FY2024 | -$58.0M | -1.7% |
| FY2023 | -$57.1M | -2.5% |
| FY2022 | -$55.7M | -25.6% |
| FY2021 | -$44.3M | -14.5% |
| FY2020 | -$38.7M | -20.8% |
| FY2019 | -$32.0M | +7.4% |
| FY2018 | -$34.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice